Status:
ACTIVE_NOT_RECRUITING
Treatment of Anxiety Disorders for Children and Adolescents in Regular Outpatient Clinics
Lead Sponsor:
Helse Stavanger HF
Collaborating Sponsors:
Helse Vest
Conditions:
Anxiety Disorders
Eligibility:
All Genders
7-17 years
Brief Summary
The purpose of this study is to examine the content of the treatment being delivered for anxiety disorders for children and adolescents in the regular outpatient clinics in western Norway. The study w...
Eligibility Criteria
Inclusion
- Clinical diagnosis of an anxiety disorder (including PTSD and OCD) based on the diagnostic interview ADIS (ADIS-C/P; Silverman \& Albano, 1996).
- The anxiety disorder is the patients primary diagnosis.
- Informed concent is given.
Exclusion
- The patient is in need for other primary treatment intervention (e.g., psychosis, suicidality risk)
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT02218996
Start Date
August 1 2014
End Date
December 31 2029
Last Update
December 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BUPA Helse Stavanger
Stavanger, Rogaland, Norway, 4011